SynerFuse named Adeel Khan, MD, as vice president of regenerative medicine, according to a March 24 news release shared with Becker’s.
Dr. Khan is a physician and regenerative medicine expert, and he was one of the first researchers in Canada to publish on intraosseous PRP.
“I am honored to serve as vice president of regenerative medicine at Synerfuse,” Dr. Khan said in the release. “This position enables me to concentrate on driving clinically informed innovation that delivers tangible improvements in patient outcomes while supporting the thoughtful adoption of new technologies. SynerFuse is taking an integrated approach that could reshape how clinicians manage one of the most common and debilitating conditions in healthcare.”
SynerFuse develops non-opioid solutions for patints with chronic lower back and lower leg pain.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
